232 related articles for article (PubMed ID: 12738234)
1. Mechanism of cyclooxygenase-2 upregulation in late preconditioning.
Xuan YT; Guo Y; Zhu Y; Han H; Langenbach R; Dawn B; Bolli R
J Mol Cell Cardiol; 2003 May; 35(5):525-37. PubMed ID: 12738234
[TBL] [Abstract][Full Text] [Related]
2. IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2.
Dawn B; Xuan YT; Guo Y; Rezazadeh A; Stein AB; Hunt G; Wu WJ; Tan W; Bolli R
Cardiovasc Res; 2004 Oct; 64(1):61-71. PubMed ID: 15364614
[TBL] [Abstract][Full Text] [Related]
3. Inducible nitric oxide synthase modulates cyclooxygenase-2 activity in the heart of conscious rabbits during the late phase of ischemic preconditioning.
Shinmura K; Xuan YT; Tang XL; Kodani E; Han H; Zhu Y; Bolli R
Circ Res; 2002 Mar; 90(5):602-8. PubMed ID: 11909825
[TBL] [Abstract][Full Text] [Related]
4. An essential role of the JAK-STAT pathway in ischemic preconditioning.
Xuan YT; Guo Y; Han H; Zhu Y; Bolli R
Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9050-5. PubMed ID: 11481471
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotection during the final stage of the late phase of ischemic preconditioning is mediated by neuronal NO synthase in concert with cyclooxygenase-2.
Wang Y; Kodani E; Wang J; Zhang SX; Takano H; Tang XL; Bolli R
Circ Res; 2004 Jul; 95(1):84-91. PubMed ID: 15166094
[TBL] [Abstract][Full Text] [Related]
6. Role of the protein kinase C-epsilon-Raf-1-MEK-1/2-p44/42 MAPK signaling cascade in the activation of signal transducers and activators of transcription 1 and 3 and induction of cyclooxygenase-2 after ischemic preconditioning.
Xuan YT; Guo Y; Zhu Y; Wang OL; Rokosh G; Messing RO; Bolli R
Circulation; 2005 Sep; 112(13):1971-8. PubMed ID: 16172266
[TBL] [Abstract][Full Text] [Related]
7. Endothelial nitric oxide synthase plays an obligatory role in the late phase of ischemic preconditioning by activating the protein kinase C epsilon p44/42 mitogen-activated protein kinase pSer-signal transducers and activators of transcription1/3 pathway.
Xuan YT; Guo Y; Zhu Y; Wang OL; Rokosh G; Bolli R
Circulation; 2007 Jul; 116(5):535-44. PubMed ID: 17606840
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy with inducible nitric oxide synthase protects against myocardial infarction via a cyclooxygenase-2-dependent mechanism.
Li Q; Guo Y; Xuan YT; Lowenstein CJ; Stevenson SC; Prabhu SD; Wu WJ; Zhu Y; Bolli R
Circ Res; 2003 Apr; 92(7):741-8. PubMed ID: 12702642
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits.
Shinmura K; Tang XL; Wang Y; Xuan YT; Liu SQ; Takano H; Bhatnagar A; Bolli R
Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10197-202. PubMed ID: 10963682
[TBL] [Abstract][Full Text] [Related]
10. COX-2 mediates morphine-induced delayed cardioprotection via an iNOS-dependent mechanism.
Jiang X; Shi E; Nakajima Y; Sato S
Life Sci; 2006 Apr; 78(22):2543-9. PubMed ID: 16325209
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning.
Bolli R; Shinmura K; Tang XL; Kodani E; Xuan YT; Guo Y; Dawn B
Cardiovasc Res; 2002 Aug; 55(3):506-19. PubMed ID: 12160947
[TBL] [Abstract][Full Text] [Related]
12. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene.
Guo Y; Jones WK; Xuan YT; Tang XL; Bao W; Wu WJ; Han H; Laubach VE; Ping P; Yang Z; Qiu Y; Bolli R
Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11507-12. PubMed ID: 10500207
[TBL] [Abstract][Full Text] [Related]
13. Ischemic preconditioning upregulates inducible nitric oxide synthase in cardiac myocyte.
Wang Y; Guo Y; Zhang SX; Wu WJ; Wang J; Bao W; Bolli R
J Mol Cell Cardiol; 2002 Jan; 34(1):5-15. PubMed ID: 11812160
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of IFN-gamma-mediated inducible nitric oxide synthase induction by the peroxisome proliferator-activated receptor gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway.
Chen CW; Chang YH; Tsi CJ; Lin WW
J Immunol; 2003 Jul; 171(2):979-88. PubMed ID: 12847270
[TBL] [Abstract][Full Text] [Related]
15. COX-2-derived prostacyclin mediates opioid-induced late phase of preconditioning in isolated rat hearts.
Shinmura K; Nagai M; Tamaki K; Tani M; Bolli R
Am J Physiol Heart Circ Physiol; 2002 Dec; 283(6):H2534-43. PubMed ID: 12388283
[TBL] [Abstract][Full Text] [Related]
16. Curcumin suppresses Janus kinase-STAT inflammatory signaling through activation of Src homology 2 domain-containing tyrosine phosphatase 2 in brain microglia.
Kim HY; Park EJ; Joe EH; Jou I
J Immunol; 2003 Dec; 171(11):6072-9. PubMed ID: 14634121
[TBL] [Abstract][Full Text] [Related]
17. Gastric preconditioning induced by short ischemia: the role of prostaglandins, nitric oxide and adenosine.
Konturek SJ; Brzozowski T; Pajdo R; Konturek PC; KwiecieĊ S; Sliwowski Z; Pawlik M; Ptak A; Drozdowicz D; Hahn EG
Med Sci Monit; 2001; 7(4):610-21. PubMed ID: 11433185
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-1 mediates the final stage of morphine-induced delayed cardioprotection in concert with cyclooxygenase-2.
Jiang X; Shi E; Nakajima Y; Sato S; Ohno K; Yue H
J Am Coll Cardiol; 2005 May; 45(10):1707-15. PubMed ID: 15893191
[TBL] [Abstract][Full Text] [Related]
19. Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia.
Nogawa S; Forster C; Zhang F; Nagayama M; Ross ME; Iadecola C
Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10966-71. PubMed ID: 9724813
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 downregulates inducible nitric oxide synthase in rat intestinal epithelial cells.
Kobayashi O; Miwa H; Watanabe S; Tsujii M; Dubois RN; Sato N
Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G688-96. PubMed ID: 11518681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
